Replies to post #314066 on Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

And, the testing (P 1-3), sales staff and advertising, product costs and anything else is shouldered by Fox, at maybe $100 million or so, my best guess, and that is what it is, just a guess. At $0 cost to IPIX and a huge PR boost if successful. Hoping we see similar from AS.

[loanranger]

"You said that we get 6% of whatever upfront payments, milestone payments and royalties that Fox receives. How great is that when it cost IPIX nothing!"

It IS great. It's just not as great as LC's math, which assumed that Fox itself would sell the product into the market, would suggest.
Fox's position is analogous to IPIX's relative to AS. Just as IPIX received an upfront payment from AS and hopes to receive milestone payments and royalties, FOX would hope to develop an anti-fungal and receive those things from whomever they were able to license it to.....for their ultimate sale to the end users. IPIX would get 6% of THAT.

It IS a revenue stream that no one expected and as such is obviously a good thing, but it requires that Fox develop a product and license it and that sales occur by whoever they license it to at some point. IPIX won't get 6% of those sales as they hopefully will from any sales by AS. The relationships are very different.
That's based on my understanding of the PR, which I would expect to be consistent with the agreement itself.